Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Ultragenyxultragenyx.comUltragenyx is a biopharmaceutical company focused on developing and commercializing innovative medicines for rare and ultra-rare diseases. The company has a robust clinical pipeline and aims to deliver transformative therapies for conditions that have never been treated before.
Parse Score
Sources
clinicaltrialsarena.com shapes more of what AI says about Ultragenyx than any other source, at 50% of its citations.
pmc.ncbi.nlm.nih.gov
